First Header Logo Second Header Logo

Connection

Louis Koman to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Louis Koman has written about Cost-Benefit Analysis.
Louis Koman
Connection Strength
0.012
Cost-Benefit Analysis
  1. Balkrishnan R, Camacho FT, Smith BP, Shilt JS, Jacks LK, Koman LA, Rascati KL, Mooney JF. Cost impact of botulinum toxin use in Medicaid-enrolled children with cerebral palsy. J South Orthop Assoc. 2002; 11(2):71-9.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.